Mislabeled Device, Unreported Deaths Draw FDA Warning Letter for iRhythm

iRhythm Technologies’ mislabeling of a cardiac monitor and its component software as well as failure to report serious adverse events, including two deaths, netted the devicemaker an FDA warning in late May.
Source: Drug Industry Daily